ClinicalTrials.govpublic full text
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
type 2 diabetes, diabetes mellitus, noninsulin-dependent diabetes mellitus, glucose metabolism disorders, metabolic diseases, endocrine system diseases, revita system, anti-diabetic medications, duodenal mucosal resurfacing, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 852399
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.